In 2010, recurrent heterozygous mutations of the EZH2 catalytic SET domain in 22% of Diffuse large B-cell lymphomas (DLBCLs) and 10% of follicular lymphomas (FLs) were reported for the first time (Fig. 6; Morin et al. 2010). This evidence concerns the gene EZH2 and follicular lymphoma.